CLINICAL_TRIALS
trial_result
· 2016-07-12
Clinical Trial Update: Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia [Phase 2]
Summary
Phase 2 study evaluating carboplatin plus topotecan in relapsed acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 2 | Status: COMPLETED